Yisu Liu, Guangpu Wu, Jiang Zhu, Yao Jiang and Hui Liu
{"title":"阳离子柱芳烃与外排泵抑制剂杂化物对革兰氏阴性菌的协同作用。","authors":"Yisu Liu, Guangpu Wu, Jiang Zhu, Yao Jiang and Hui Liu","doi":"10.1039/D5MD00262A","DOIUrl":null,"url":null,"abstract":"<p >Novel antibiofilm agents were designed by integrating cationic pillararene with an efflux pump inhibitor. The hybrid compounds were prepared and characterized using NMR and HRMS. These compounds exhibited potent activity to inhibit biofilm formation and disrupt the outer membrane in Gram-negative bacteria. In addition, the synergistic effect of the hybrid compounds was observed in combination with antibiotics, especially against <em>P. aeruginosa</em>. The hybridization strategy not only reduced the dosages required for the efflux pump inhibitor but also enhanced the antibacterial efficacy of antibiotics, making this a promising approach for developing antibacterial drugs.</p>","PeriodicalId":88,"journal":{"name":"MedChemComm","volume":" 8","pages":" 3778-3786"},"PeriodicalIF":3.5970,"publicationDate":"2025-06-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Synergistic effect of the hybrid compounds of cationic pillararene and an efflux pump inhibitor against Gram-negative bacteria†\",\"authors\":\"Yisu Liu, Guangpu Wu, Jiang Zhu, Yao Jiang and Hui Liu\",\"doi\":\"10.1039/D5MD00262A\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p >Novel antibiofilm agents were designed by integrating cationic pillararene with an efflux pump inhibitor. The hybrid compounds were prepared and characterized using NMR and HRMS. These compounds exhibited potent activity to inhibit biofilm formation and disrupt the outer membrane in Gram-negative bacteria. In addition, the synergistic effect of the hybrid compounds was observed in combination with antibiotics, especially against <em>P. aeruginosa</em>. The hybridization strategy not only reduced the dosages required for the efflux pump inhibitor but also enhanced the antibacterial efficacy of antibiotics, making this a promising approach for developing antibacterial drugs.</p>\",\"PeriodicalId\":88,\"journal\":{\"name\":\"MedChemComm\",\"volume\":\" 8\",\"pages\":\" 3778-3786\"},\"PeriodicalIF\":3.5970,\"publicationDate\":\"2025-06-04\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"MedChemComm\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://pubs.rsc.org/en/content/articlelanding/2025/md/d5md00262a\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"Pharmacology, Toxicology and Pharmaceutics\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"MedChemComm","FirstCategoryId":"1085","ListUrlMain":"https://pubs.rsc.org/en/content/articlelanding/2025/md/d5md00262a","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"Pharmacology, Toxicology and Pharmaceutics","Score":null,"Total":0}
Synergistic effect of the hybrid compounds of cationic pillararene and an efflux pump inhibitor against Gram-negative bacteria†
Novel antibiofilm agents were designed by integrating cationic pillararene with an efflux pump inhibitor. The hybrid compounds were prepared and characterized using NMR and HRMS. These compounds exhibited potent activity to inhibit biofilm formation and disrupt the outer membrane in Gram-negative bacteria. In addition, the synergistic effect of the hybrid compounds was observed in combination with antibiotics, especially against P. aeruginosa. The hybridization strategy not only reduced the dosages required for the efflux pump inhibitor but also enhanced the antibacterial efficacy of antibiotics, making this a promising approach for developing antibacterial drugs.
期刊介绍:
Research and review articles in medicinal chemistry and related drug discovery science; the official journal of the European Federation for Medicinal Chemistry.
In 2020, MedChemComm will change its name to RSC Medicinal Chemistry. Issue 12, 2019 will be the last issue as MedChemComm.